These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Observations on "clearance" of phosphorus (Cp) in acromegaly and in hypopituitarism]. Piancino G; Modica A; Martini PF Boll Soc Ital Biol Sper; 1966 Apr; 42(7):369-73. PubMed ID: 5949374 [No Abstract] [Full Text] [Related]
6. [Growth hormones and their clinical use]. Shizume K; Irie M; Sakuma M; Tsushima T Naika; 1967 Sep; 20(3):404-15. PubMed ID: 4871764 [No Abstract] [Full Text] [Related]
7. Advances in the treatment of endocrine disorders. Hall R Practitioner; 1969 Oct; 203(216):494-500. PubMed ID: 4311092 [No Abstract] [Full Text] [Related]
9. [Secretion of growth hormone and its anomalies]. Irie M; Tsushima T; Shizume K Saishin Igaku; 1968 May; 23(5):938-44. PubMed ID: 4883384 [No Abstract] [Full Text] [Related]
10. [Static and dynamic results of radioimmunoassay of the growth hormone in endocrine diseases]. Simionescu L Stud Cercet Endocrinol; 1971; 22(3):181-95. PubMed ID: 5127266 [No Abstract] [Full Text] [Related]
11. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. Laron Z; Pertzelan A; Karp M; Kowadlo-Silbergeld A; Daughaday WH J Clin Endocrinol Metab; 1971 Aug; 33(2):332-42. PubMed ID: 4935640 [No Abstract] [Full Text] [Related]
12. [Clinical studies on pituitary growth hormone. II. On the serum level in normal subjects and patients with various disorders]. Isobe I Naika Hokan; 1970 Sep; 17(9):253-69. PubMed ID: 5531456 [No Abstract] [Full Text] [Related]
13. [Inhibitory factor in endocrine growth disturbances]. Cízková J; Ulrychová M; Růzicka V Cesk Pediatr; 1972 Oct; 27(10):478-9. PubMed ID: 5078507 [No Abstract] [Full Text] [Related]
14. [Reserve capacity of hypophyseal trophic hormones in endocrine diseases. TSH reserve capacity in thyroid diseases]. Julesz J; Laczi F; László F Orv Hetil; 1979 Jul; 120(30):1805-9. PubMed ID: 582463 [No Abstract] [Full Text] [Related]
15. [Diagnostic and therapeutic aspects of growth-hormone releasing factor]. von Werder K; Losa M; Müller OA Internist (Berl); 1985 May; 26(5):259-65. PubMed ID: 3924850 [No Abstract] [Full Text] [Related]
16. [On radio-immunologic determination of growth hormone in blood]. Melani F; Conrads R; Sorge F; Bartelt KM; Pfeiffer EF Verh Dtsch Ges Inn Med; 1965; 71():343-6. PubMed ID: 4291176 [No Abstract] [Full Text] [Related]
17. The effect of dihydrosomatostatin in dwarfism with high plasma immunoreactive growth hormone. Laron Z; Pertzelan A; Doron M; Assa S; Keret R Horm Metab Res; 1977 Jul; 9(4):338-9. PubMed ID: 892700 [No Abstract] [Full Text] [Related]
19. [The serum sulfation factor. Its value for an eventual indirect determination of somatotropic activity]. Salesses A Rev Fr Etud Clin Biol; 1967 Dec; 12(10):946-57. PubMed ID: 4877203 [No Abstract] [Full Text] [Related]
20. [Effect of human growth hormone on long term growth of 8 persons with hypophyseal dwarfism]. Elsair J Tunis Med; 1967; 45(3):187-8 passim. PubMed ID: 5622121 [No Abstract] [Full Text] [Related] [Next] [New Search]